Influence of Therapy of Cervical Neoplasias on Immunological and Apoptotic Parameters
https://doi.org/10.31550/1727-2378-2023-22-1-16-20
Abstract
Aim: Evaluation of immune response factors in the treatment of mild cervical neoplasia against the background of human papillomavirus in patients of childbearing age.
Design: Prospective study.
Materials and methods. The study included a survey of 210 patients of fertile age. Among them were 150 patients with human papillomavirus (HPV) and cervical intraepithelial neoplasia, established by histological examination. Patients underwent Pap test, extended colposcopy, determination of HPV type and viral load. Patients with suspected pathology of the cervical zone underwent multifocal biopsy of the cervix. When analyzing changes in the cervix zone, the levels of interferon-ã, interleukin-18, caspase 3 and 9 were evaluated.
Results. Among patients with cervical neoplasia of the first degree, the concentration of caspase 3, caspase 9 and interferon-ã at the first stage of the examination was higher (p < 0.05) than the values in the control group (among conditionally healthy women without viral load), while interleukin-18 was significantly lower (p < 0.05). In subgroups I and II, after 3 and 12 months, the concentrations of the studied parameters significantly differed from those in the control group and values before treatment (p < 0.05), while, after 12 months, the values of caspase 3 and caspase 9 in the subgroup where therapy was carried out (subgroup II) were significantly lower than in subgroup I. Also, among the patients, there was a statistical difference in the values of the cytokine series, however, the level of interleukin-18 in subgroup II after 10 days and 12 months was significantly higher than in subgroup I. fluctuations in indicators made it possible to justify the use of immunocorrective therapy for the treatment of a mild neoplastic process of the cervical zone.
Conclusion. The results of the study allow optimizing approaches to the treatment of women of childbearing age with mild cervical neoplasia on the background of HPV.
About the Authors
O. P. Vinogradova
Penza Institute for Postgraduate Medical Education — branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
7 Stasova Str., Penza, 440060
O. I. Artemova
Penza State University
Russian Federation
Russian Federation
40 Krasnaya Str., Penza, 440026
O. V. Epifanova
Penza Institute for Postgraduate Medical Education — branch of the Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
7 Stasova Str., Penza, 440060
References
1. Zarochentseva N.V., Dzhidzhikhiya L.K., Nabieva V.N. Monitoring of patients with cervical intraepithelial neoplasia after excisional treatment. Gynecology, Obstetrics and Perinatology. 2021;20(1):113– 120. (in Russian). DOI: 10.20953/1726-1678-2021-1-113-120
2. Vinogradova O.P., Andreeva N.A., Artyomova O.I., Epifanova O.V. Cervical intraepithelial neoplasia II degree: the effectiveness of antiviral therapy. Doctor.Ru. 2022; 21(1):54–58. (in Russian). DOI: 10.31550/1727-2378-2022-21-1-54-58
3. Kocken M., Helmerhorst T., Berkhof J. et al. Risk of recurrent highgrade cervical intraepithelial neoplasia after successful treatment: a longterm multi-cohort study. Lancet Oncol. 2018;12(5):441–450. DOI: 10.1016/S1470-2045(18)70078-X
4. Chen L., Liu L., Tao X. Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP. Zhonghua Fu Chan Ke Za Zhi. 2019;54(8):534–540. DOI: 10.3760/cma.j.issn.0529-567x.2019.08.006
5. Vinogradova O.P., Artemova O.I. The efficacy of human papillomavirus elimination during treatment of cervical disorders. Doctor.Ru. 2020:19(8):80–85. (in Russian). DOI: 10.31550/1727-2378-2020-19-8-80-85
6. Loopik D., IntHout J., Ebisch R. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: a population-based cohort study with 80,442 women. Gynecol. Oncol. 2020;157(1):195–201. DOI: 10.1016/j.ygyno.2020.01.023
7. Joura E., Garland S., Paavonen J. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ. 2019;344:e1401. DOI: 10.1136/bmj.e1401
8. Kanayama S., Nakagawa E., Ueno S. et al. Outcomes of laser conization for cervical intraepithelial neoplasia 2–3 and microinvasive cervical cancer. World J. Oncol. 2017;5(2):62–67. DOI: 10.14740/wjon799w
9. Vinogradova O.P., Andreeva N.A., Artemova O.I., Epifanova O.V. Changes in immune response factors in the treatment of cervical intraepithelial neoplasia. Siberian Medical Review. 2022;(6):71–77. (in Russian). DOI: 10.20333/25000136-2022-6-71-77
10. Massad L., Einstein M., Huh W. 2017 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet. Gynecol. 2018;121(4):829–846. DOI: 10.1097/AOG.0b013e3182883a34
11. Morrell S., Qian L. A whole-population profile of HPV testing as a test of cure for high grade cervical dysplasia in NSW, Australia J. Med. Screen. 2018;21(3):151–162. DOI: 10.1177/0969141314542667
12. Lahousen M., Pickel H. Cervical intraepithelial neoplasia III: longterm follow up after cold-knife conization with involved margins. Obstet. Gynecol. 2019;99(2):193–196. DOI: 10.1016/s0029-7844(01)01683-0
13. Zarochentseva N.V., Dzhidzhikhiya L.K., Nabieva V.N. Recurrence of cervical intraepithelial neoplasia after excisional treatment. Gynecology, Obstetrics and Perinatology. 2020;19(2):68–77. (in Russian). DOI: 10.20953/1726-1678-2020-2-68-77
14. Soutter W., Moss B., Perryman K., Kyrgiou M. Long-term compliance with follow-up after treatment for cervical intra-epithelial neoplasia. Acta Obstet. Gynecol. Scand. 2018;91(9):1103–1108. DOI: 10.1111/j.1600-0412.2018.01477.x
15. Velentzis L., Brotherton J., Canfell K. Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions. Climacteric. 2019;22(6):596–602. DOI: 10.1080/13697137.2019.1600500
16. Wang X., Li L., Bi Y., Wu H. The effects of different instruments and suture methods of conization for cervical lesions. Sci. Rep. 2019;9(1):19114. DOI: 10.1038/s41598-019-55786-4
17. Weinmann S., Naleway A., Swamy G. Pregnancy outcomes after treatment for cervical cancer precursor lesions: an observational study. PLoS One. 2017;12(1):0165276. DOI: 10.1371/journal.pone.0165276
18. Athanasiou A., Veroniki A., Efthimiou O. Comparative efficacy and complication rates after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE Group. BMJ Open. 2019;9(8):028008. DOI: 10.1136/bmjopen-2018-02800
19.
Review
For citations:
Vinogradova O.P., Artemova O.I., Epifanova O.V. Influence of Therapy of Cervical Neoplasias on Immunological and Apoptotic Parameters. Title. 2023;22(1):16-20. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-1-16-20
Views:
9
Email this article 